Little Casper’s Cause of Death: The Gruesome Truth That Demands Attention

Casper O’Brien weighed 255 pounds at the time of his death. The seven-year-old, who was a little over 4 feet 2 inches tall, was no longer breathing when emergency responders arrived at his family’s home in Flint Township, Michigan, on November 4, 2025. He died before reaching the hospital.

The Genesee County Medical Examiner determined that Casper died from dilated cardiomyopathy, a serious condition in which the heart’s chambers become enlarged and weakened, leaving the organ unable to pump blood properly. Morbid obesity was listed as a contributing factor in his official cause of death.

Now, eight months later, his parents are facing charges more commonly associated with acts of violence. Damien O’Brien, 40, and Jessica O’Brien, 41, were charged in June with second-degree murder, torture and three counts of second-degree child abuse. No trial date has been set.

According to investigators, Casper’s mother said his typical daily meals included a large bag of potato chips, french fries, carbonated water and apple juice. She also told them she cleaned him with baby wipes because he did not like water.

At the time he died, Casper was nonverbal, confined to bed and suffering from severe bed sores.

Records show Casper’s last visit with a medical provider was in February 2024, about 21 months before his death, when he weighed 104 pounds. He was referred to a pediatric endocrinologist, but his parents did not schedule the appointment.

The case is extraordinary by almost any standard, but the legal question it raises is not entirely unprecedented. Courts in at least six states — New York, Texas, Pennsylvania, New Mexico, Indiana and California — have previously examined whether a child’s morbid obesity alone can amount to medical neglect under the law.

In one South Carolina case from 2009, a mother was accused of criminal mistreatment after her 14-year-old son’s weight climbed to 555 pounds.

A 2007 New York case involved a 261-pound teenage girl and resulted in court-ordered nutritional counseling rather than a criminal charge.

What sets the O’Brien case apart is the severity of the outcome and the decision to treat it as a murder case rather than a civil child-welfare matter. But the underlying legal theory is that a child’s dangerous weight can meet the threshold for criminal neglect.

Casper was too young for any FDA-approved obesity medication, but his parent’s case is being prosecuted after GLP-1 drugs have changed the treatment landscape for adolescents.

Wegovy, the brand name for the GLP-1 drug semaglutide, was approved by the FDA for adolescents aged 12 and older with obesity in December 2022. Saxenda, a daily injection, was approved for the same age group two years earlier.

CDC data show that obesity-medication prescribing among adolescents ages 12 to 17 with obesity rose from 0.1 percent in 2020 to 0.5 percent in 2023, a roughly 300 percent increase. Even so, fewer than one percent of adolescents with obesity received a prescription in 2023 and most prescriptions went to teens with severe obesity.

Dr Fatima Cody Stanford, an obesity medicine physician at Massachusetts General Hospital and an associate professor of medicine and pediatrics at Harvard Medical School, says the new drugs have ‘helped shift the conversation, reinforcing that obesity is a chronic, biologically driven disease. But it’s important to be clear that these treatments are not used in young children. They are approved for adolescents, not for a 7-year-old.’

For younger children, she says, the medical response is not Wegovy, but sustained, closely supervised care. ‘Treatment focuses on intensive, family-based care: nutrition, physical activity, behavioral support, and close medical follow-up,’ Stanford says. ‘Medications and bariatric surgery are not part of standard care at that age.’

If pediatric obesity is increasingly understood as a chronic disease with medical treatments, parents may face more pressure to seek care. Stanford says severe pediatric obesity requires ‘coordinated, multidisciplinary care,’ and families often face ‘real barriers, like access, cost, transportation and competing demands.’

In her view, obesity should become a medical-neglect issue only at the far edge of the spectrum. ‘Medical neglect in obesity is rare and should only be considered in extreme situations where a child is at imminent risk of serious harm, and all efforts to engage the family in care have failed,’ she says.

Elizabeth Bartholet has spent close to five decades warning against too much caution. She’s the Morris Wasserstein Public Interest Professor of Law, Emeritus, at Harvard Law School, where she founded and directed the Child Advocacy Program.

Her long-standing position is that American child welfare law leans too far toward protecting parents rather than children.

‘As a general matter, I believe that the child welfare system is much too reluctant to intervene when parents fail their children in health care and medical treatment,’ Bartholet says. ‘Child welfare authorities are often reluctant to intervene unless the child’s life is at risk. They are unduly deferential to parent rights.’

Bartholet rejects any standard that leaves children less protected when their health is on the line. ‘I don’t think there should be a less protection of children standard in extreme obesity cases,’ she says. ‘It may be correlated with poverty and other conditions, but I don’t see why that means we should punish the children by putting them even further at risk for bad health and in extreme cases death.’

Taken together, these experts don’t settle the question so much as define its boundaries.

What happens next depends on whether the next prosecutor to consider a case like this reads Genesee County as a warning about overreach or as proof the system waited too long.

The law can decide what the O’Briens owed Casper only after the fact. The harder question is what everyone else owed him while he was still alive.